Covered recipient · General Payments record
MANUBHAI S PATEL
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$6,968.81
- Reported across 367 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,101.24 | 56 |
| Education | $199.90 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $174.67 | 6 |
| Celgene Corporation | $131.28 | 8 |
| Gilead Sciences, Inc. | $121.75 | 4 |
| Astellas Pharma US Inc | $114.66 | 2 |
| E.R. Squibb & Sons, L.L.C. | $102.56 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $74.48 | 4 |
| GlaxoSmithKline, LLC. | $60.63 | 3 |
| ABBVIE INC. | $55.15 | 2 |
| Daiichi Sankyo Inc. | $54.50 | 2 |
| Acerta Pharma LLC | $45.33 | 2 |
| GENZYME CORPORATION | $37.87 | 2 |
| Kite Pharma, Inc. | $36.84 | 2 |
| Octapharma USA, Inc. | $36.63 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.94 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $22.90 | 1 |
| Merck Sharp & Dohme Corporation | $21.62 | 1 |
| Inari Medical, Inc. | $21.35 | 1 |
| Genentech USA, Inc. | $20.10 | 1 |
| Karyopharm Therapeutics Inc. | $20.03 | 1 |
| SpringWorks Therapeutics, Inc. | $18.84 | 1 |
| BeiGene USA, Inc. | $18.57 | 1 |
| Exelixis Inc. | $17.70 | 1 |
| ARRAY BIOPHARMA INC | $16.96 | 1 |
| Incyte Corporation | $16.72 | 1 |
| Spectrum Pharmaceuticals Inc. | $16.61 | 1 |
| Mirati Therapeutics, Inc. | $16.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (58)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.